[Federal Register Volume 63, Number 52 (Wednesday, March 18, 1998)]
[Notices]
[Page 13265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-6960]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke, Division 
of Extramural Activities; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings:

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel (Telephone Conference Call).
    Date: March 26, 1998.
    Time: 11:00 a.m.
    Place: National Institutes of Health, 7550 Wisconsin Avenue, 
Room 9C10, Bethesda, MD 20892.
    Contact Person: Dr. Katherine Woodbury-Harris, Mr. Phillip 
Wiethorn, Scientific Review Administrators, NINDS, National 
Institutes of Health, 7550 Wisconsin Avenue, Room 9C10, Bethesda, MD 
20892, (301) 496-9223.
    Purpose/Agenda: To review and evaluate Phase I SBIR Contract 
Proposal(s).
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel. (Telephone Conference Call).
    Date: April 10, 1998.
    Time: 12:00 p.m. 
    Place: National Institutes of Health, 7550 Wisconsin Avenue, 
Room 9C10, Bethesda, MD 20892.
    Contact Person: Dr. Paul A. Sheehy, Scientific Review 
Administrator, NINDS, National Institutes of Health, 7550 Wisconsin 
Avenue, Room 9C10, Bethesda, MD 20892, (301) 496-9223.
    Purpose/Agenda: To review and evaluate a grant application.
    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program No. 93.853, Clinical 
Research Related to Neurological Disorders; No. 93.854, Biological 
Basis Research in the Neurosciences)

    Dated: March 11, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-6960 Filed 3-17-98; 8:45 am]
BILLING CODE 4140-01-M